(Q39904256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8+ T cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Naoko Imai

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hiroaki Ikeda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Isao Tawara

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

241-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19089817%20AND%20SRC:MED&resulttype=core&format=json

Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Polyfunctional T cell responses are a hallmark of HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Human T cell responses against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Cancer immunotherapy: a treatment for the masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Adoptive immunotherapy for cancer: building on success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Principles of adoptive T cell cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Mini-review: overcoming tumor-intrinsic resistance to immune effector function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Toward improved immunocompetence of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Regulatory T cells in autoimmmunity*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Regulatory T cells: key controllers of immunologic self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Regulatory T cells in the control of immune pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

T cells compete for access to antigen-bearing antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Selection of highly transfectable variant from mouse mastocytoma P815.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

Seventeen-colour flow cytometry: unravelling the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

7 January 2021

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

7 January 2021

Tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

7 January 2021

Expression of TNFalpha by CD3+ and F4/80+ cells following irradiation preconditioning and allogeneic spleen cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838824

7 January 2021